(Q43694138)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483242%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Expression of alpha-synuclein in the human brain: relation to Lewy body disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483242%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483242%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

K Wirdefeldt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483242%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

N Bogdanovic

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483242%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

H Payami

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483242%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Schalling

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483242%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

G Murdoch

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483242%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

1 reference

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483242%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

published in

Molecular Brain Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483242%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483242%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483242%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

58-65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483242%20AND%20SRC:MED&resulttype=core&format=json

NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Neural expression profile of alpha-synuclein in developing human cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Widespread alterations of alpha-synuclein in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Neuropathology of synuclein aggregates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Synucleinopathies: clinical and pathological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Protein nitration in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Genetic classification of primary neurodegenerative disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Identification of two distinct synucleins from human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Reduced expression of the G209A alpha-synuclein allele in familial Parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Developmental expression of alpha-synuclein in rat hippocampus and cerebral cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

1 reference

7 January 2021

Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Cortical Lewy body-containing neurons are pyramidal cells: laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900150-4

7 January 2021

10.1016/S0169-328X(01)00150-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483242%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference